Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2023 Sep 1;77(3):e65-e66.
doi: 10.1097/MPG.0000000000003871. Epub 2023 Jun 22.

Reply to: Therapeutic Drug Monitoring for IBD Children on Thioguanine

Affiliations
Comment

Reply to: Therapeutic Drug Monitoring for IBD Children on Thioguanine

Ahmed B Bayoumy et al. J Pediatr Gastroenterol Nutr. .
No abstract available

PubMed Disclaimer

Comment on

  • Safety of Thioguanine in Pediatric Inflammatory Bowel Disease: A Multi-Center Case Series.
    Bayoumy AB, Jagt JZ, van Wering HM, de Ridder L, Hummel T, Wolters VM, Stapelbroek J, Benninga MA, Mulder CJJ, de Boer NKH, de Meij TGJ; Kids with Crohn’s, Colitis (KiCC) Working Group for Collaborative Paediatric IBD Research in the Netherlands. Bayoumy AB, et al. J Pediatr Gastroenterol Nutr. 2022 Dec 1;75(6):e111-e115. doi: 10.1097/MPG.0000000000003621. Epub 2022 Sep 20. J Pediatr Gastroenterol Nutr. 2022. PMID: 36136124 Free PMC article.
  • Therapeutic Drug Monitoring for IBD Children on Thioguanine.
    Florin TH, Duley JA. Florin TH, et al. J Pediatr Gastroenterol Nutr. 2023 Sep 1;77(3):e64-e65. doi: 10.1097/MPG.0000000000003870. Epub 2023 Jun 22. J Pediatr Gastroenterol Nutr. 2023. PMID: 37346029 No abstract available.

References

    1. Bayoumy AB, Jagt JZ, van Wering HM, et al. Safety of thioguanine in pediatric inflammatory bowel disease: a multi-center case series. J Pediatr Gastroenterol Nutr 2022;75:e111–5.
    1. Florin TH, Duley JA. Therapeutic drug monitoring for IBD children on thioguanine. J Pediatr Gastroenterol Nutr 2023; Epub ahead of print.
    1. De Boer N, Wilhelm A, van Bodegraven A, et al. Guideline therapeutic drug monitoring thiopurines. 2018. https://tdm-monografie.org/monografie/thiopurines . Accessed February 10, 2023.
    1. Dubinsky MC, Vasiliauskas EA, Singh H, et al. 6-Thioguanine can cause serious liver injury in inflammatory bowel disease patients. Gastroenterology 2003;125:298–303.
    1. Derijks LJ, de Jong DJ, Gilissen LP, et al. 6-Thioguanine seems promising in azathioprine- or 6-mercaptopurine-intolerant inflammatory bowel disease patients: a short-term safety assessment. Eur J Gastroenterol Hepatol 2003;15:63–7.